Research Studies

Published research on HBOT for Refractory Osteomyelitis

← Browse all conditions in the PubMed Research Library

These publications include different levels of evidence—not necessarily clinical trials. PubMed indexing is not proof of benefit or an endorsement. Summaries are based on available PubMed abstracts, not a formal full-text quality assessment. Read the limitations as well as the findings; some papers report no benefit or potential harms.

Clinical review 2021

Hyperbaric oxygen for refractory osteomyelitis. (opens PubMed in a new tab)

Hart BB — Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc

Plain English Summary

Reviews adjunctive HBOT for bone infection persisting despite standard treatment and describes its use with antibiotics and debridement.

Limitations & context: The review states that randomized clinical trials for refractory osteomyelitis were lacking. Recommendations rely on lower-level evidence.

View on PubMed · PMID 34390634

Observational study 2024

Outcome of Chronic Foot Osteomyelitis Treated With Hyperbaric Oxygen: An Observational Study. (opens PubMed in a new tab)

Menekse S — The international journal of lower extremity wounds

Plain English Summary

Reports infection clearance in many patients receiving HBOT after debridement and antibiotics for chronic refractory foot osteomyelitis.

Limitations & context: An observational treatment series cannot determine how much of the outcome was due to HBOT rather than the accompanying care.

View on PubMed · PMID 38073097

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.